Pacific Biosciences Of California (PACB) Interest Expenses (2012 - 2026)

Pacific Biosciences Of California has reported Interest Expenses for 15 years, with the latest figure at $1.7 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses changed 0.17% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $7.0 million (down 39.89% YoY), and the FY2025 full-year result was $7.0 million, down 48.15% from the prior year.
• Interest Expenses for Q1 2026 stood at $1.7 million, roughly flat from $1.7 million in the prior quarter.
• The five-year high for Interest Expenses was $3.7 million in Q1 2022, with the low at $1.7 million in Q1 2025.
• Average Interest Expenses over 5 years is $3.0 million, with a median of $3.6 million recorded in 2023.
• Year-over-year, Interest Expenses surged 106.65% in 2022 and tumbled 51.41% in 2025.
• Tracing PACB's Interest Expenses over 5 years: stood at $3.6 million in 2022, then decreased by 2.11% to $3.6 million in 2023, then decreased by 22.79% to $2.8 million in 2024, then sank by 36.89% to $1.7 million in 2025, then changed by 0.0% to $1.7 million in 2026.
• The last three Interest Expenses figures came in at $1.7 million (Q1 2026), $1.7 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.

Peer Comparison